Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

Conditions:   Pituitary;   Pituitary Tumor;   Pituitary Carcinoma;   Pituitary Cancer Interventions:   Drug: Ipilimumab;   Drug: Nivolumab Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials